Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.

ASTRO organized content area experts to evaluate clinical data regarding the use of partial breast RT. The experts used standardized criteria for curating and ranking the quality of evidence.

This session highlights the most clinically relevant abstracts within the Genitourinary Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

The associated article is a meta-analysis reviewing published studies for SBRT for HCC with 5+ years of outcome data. 19 studies were identified that met the criteria. The article reviews those 19 studies and makes recommendations for appropriate SBRT for HCC.

Radiation oncology centers have been victims of cyberattacks in recent years.

Optimal management of leptomeningeal disease with radiation therapy is an active area of interest.

Several national societies' guidelines, including NCCN and ASCO, recommend screening of older adults with cancer with comprehensive geriatric assessment (CGA) or similar tools.

The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.